Investors NewsSearch: Oct 06, 2021Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical Officer Sep 24, 2021Rafael Holdings Continues to Expand its Management Team with a Highly Experienced Global Biopharmaceutical Executive to Build a Fully Integrated Cancer Metabolism Therapeutics Company and Announces Inducement Grant Under NYSE Rule 303A.08 Sep 17, 2021Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 Sep 14, 2021Rafael Holdings Appoints Patrick Fabbio as Chief Financial Officer Aug 24, 2021Rafael Holdings Announces Closing of $104.2 Million Private Placement Aug 20, 2021Rafael Holdings Announces $104.2 Million Private Placement Aug 17, 2021Rafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics Company Jun 23, 2021Rafael Holdings and Rafael Pharmaceuticals Management Presented at the Raymond James 2021 Human Health Innovation Conference on June 22, 2021 Jun 21, 2021Rafael Holdings Announces Strategic Merger with Rafael Pharmaceuticals to Form a Focused Late-Stage Clinical Oncology Company Jun 14, 2021Rafael Holdings Reports Third Quarter Fiscal Year 2021 Results 1 2 3 4 5 6 7 << < > >>
